ACCELERATE was jointly created in 2015 by The European Society for Paediatric Oncology (SIOP Europe), ITCC (Innovative Therapies for Children with Cancer in Europe) and CDDF within the ENCCA project (European Network for Cancer research in Children and Adolescents) – a network of excellence funded through the European Union’s Seventh Framework Programme for research, technological development and demonstration under the project ENCCA, grant agreement no HEALTH-F2-2011-261474. In March 2018, the term of the Memorandum of Understanding which described how SIOPE and CDDF collaborated in running the ACCELERATE Platform was completed. Both societies recognised the success of the Paediatric Oncology Platform Initiative and decided to discontinue their collaboration through mutual agreement. From March 2018, the activities of the ACCELERATE Platform are supported by SIOPE and ITCC. In addition, ACCELERATE made a strategic decision to strengthen international cooperation in order to improve global development of new paediatric oncology drugs and to become an organisation spanning Europe, North America, and beyond. Consequently, a new international Steering Committee has been appointed and new Terms of Reference have been established.